Citation Impact
Citing Papers
Carotenoids: biochemistry, pharmacology and treatment
2016 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer
2016
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines
2013 StandoutNobel
Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
2009
Burden of liver diseases in the world
2018 Standout
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol
2016
Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysis
2009
Hepatitis C virus and type 2 diabetes
2009
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis
2008
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
2008
Rapid Regulation of Depression-Associated Genes in a New Mouse Model Mimicking Interferon-α-Related Depression in Hepatitis C Virus Infection
2014
Animal models in the study of hepatitis C virus-associated liver pathologies
2011
Interferon-based therapy for chronic hepatitis C: current and future perspectives
2008
Interferon Lambda Alleles Predict Innate Antiviral Immune Responses and Hepatitis C Virus Permissiveness
2014 StandoutNobel
Pegylated Interferon‐α‐2a plus Ribavirin for Treatment‐Naive Asian Patients with Hepatitis C Virus Genotype 1 Infection: A Multicenter, Randomized Controlled Trial
2008
Chronic hepatitis B: Update 2009 #
2009 Standout
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Clinical features and outcomes of cirrhosis due to non‐alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C
2008
Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism
2017 StandoutNobel
Milk thistle in liver diseases: past, present, future
2010 Standout
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Progress towards elimination goals for viral hepatitis
2020
Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment
2011
The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-α2b and ribavirin in patients with HBV/HCV co-infection
2008
Hepatitis C Virus: 30 Years after Its Discovery
2019 StandoutNobel
Extrahepatic Morbidity and Mortality of Chronic Hepatitis C
2015
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Definition of rapid virologic response with a highly sensitive real-time PCR-based HCV RNA assay in peginterferon alfa-2a plus ribavirin response-guided therapy
2010
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Hepatitis B virus and hepatitis C virus dual infection
2014
Relationship between hepatitis C virus infection and type 2 diabetes mellitus: Meta-analysis
2012
Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection
2017
Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: A seventeen-year prospective cohort study
2007
Optimal therapy in genotype 1 patients
2009
Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infection
2010
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
2011 Standout
Innate Immune Responses to Hepatitis C Virus
2013 StandoutNobel
Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis
2016
Replication of hepatitis C virus
2007 StandoutNobel
Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation
2011
RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology
2020 StandoutNobel
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Polymorphisms in melanoma differentiation‐associated gene 5 link protein function to clearance of hepatitis C virus
2014 StandoutNobel
Clinical implications of interferon‐γ genetic and epigenetic variants
2014
A Sustained Virological Response to Interferon or Interferon/Ribavirin Reduces Hepatocellular Carcinoma and Improves Survival in Chronic Hepatitis C: A Nationwide, Multicentre Study in Taiwan
2006
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
2009 Standout
The HCV IRES pseudoknot positions the initiation codon on the 40S ribosomal subunit
2010 StandoutNobel
Gene Expression Profiling Indicates the Roles of Host Oxidative Stress, Apoptosis, Lipid Metabolism, and Intracellular Transport Genes in the Replication of Hepatitis C Virus
2010
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Antisense Gets a Grip on miR-122 in Chimpanzees
2010 StandoutNobel
Fast Hepatitis C Virus RNA Elimination and NS5A Redistribution by NS5A Inhibitors Studied by a Multiplex Assay Approach
2015 StandoutNobel
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
Very-Low-Density Lipoprotein (VLDL)-Producing and Hepatitis C Virus-Replicating HepG2 Cells Secrete No More Lipoviroparticles than VLDL-Deficient Huh7.5 Cells
2013
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout
Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus
2011
The spectrum of HBV/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management.
2015
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
2016 StandoutNobel
Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta‐analysis
2017
Guidelines for the management of hemophilia
2012 Standout
Works of Li‐Po Lee being referenced
Viral Hepatitis Infections in Southern Taiwan: A Multicenter Community‐based Study
2010
High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study
2005
A randomized trial of 24‐ vs. 48‐week courses of PEG interferon α‐2b plus ribavirin for genotype‐1b‐infected chronic hepatitis C patients: a pilot study in Taiwan
2005
Comparison of liver histopathology between chronic hepatitis C patients and chronic hepatitis B and C‐coinfected patients
2006
A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy
2006
Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: A community-based study
2008
Reappraisal of the Characteristics of Glucose Abnormalities in Patients With Chronic Hepatitis C Infection
2008
Serum retinol-binding protein 4 is inversely correlated with disease severity of chronic hepatitis C
2008
Polymorphism of interferon–gamma gene at position +874 and clinical characteristics of chronic hepatitis C
2006
Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial
2008
Tumor necrosis factor α promoter polymorphisms at position −308 in Taiwanese chronic hepatitis C patients treated with interferon-alpha
2003
Association between transforming growth factor-beta 1 polymorphism and virologic characteristics of chronic hepatitis C
2008
A 24‐week course of high‐dose interferon‐α plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near‐normal alanine aminotransferase levels
2006
Hepatitis C Viremia Increases the Association With Type 2 Diabetes Mellitus in a Hepatitis B and C Endemic Area: An Epidemiological Link With Virological Implication
2007
Outcome of Chronic Hepatitis C Patients who Required Early Termination of Pegylated Interferon-α plus Ribavirin Combination Therapy
2006
Viral Interaction and Responses in Chronic Hepatitis C and B Coinfected Patients with Interferon-Alpha plus Ribavirin Combination Therapy
2005